AV 4203Alternative Names: AV-4203
Latest Information Update: 12 Nov 2013
At a glance
- Originator AllaChem
- Class Antivirals; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis C
Most Recent Events
- 12 Nov 2013 Preclinical trials in Hepatitis C in USA (unspecified route)